ChiRhoClin, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1991-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.chirhoclin.com
Clinical Trials
3
Active:0
Completed:2
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Phase 3:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)Secretin for Acute Pancreatitis
- First Posted Date
- 2018-09-27
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- ChiRhoClin, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03686618
- Locations
- 🇺🇸
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
Secretin Infusion for Pain Due to Chronic Pancreatitis
- First Posted Date
- 2010-12-23
- Last Posted Date
- 2016-03-09
- Lead Sponsor
- ChiRhoClin, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01265875
- Locations
- 🇺🇸
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers
- First Posted Date
- 2010-03-16
- Last Posted Date
- 2011-12-06
- Lead Sponsor
- ChiRhoClin, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT01087801
- Locations
- 🇺🇸
Saint Louis University, Saint Louis, Missouri, United States
News
No news found